Drug Profile
Phenylephrine/tropicamide - Eyenovia
Alternative Names: ARVN004; Dx 102; MicroStat; MydCombi; Mydcombi; Mydrin-PG; Tropicamide/phenylephrine; Tropicamide/phenylephrine - EyenoviaLatest Information Update: 07 Aug 2023
Price :
$50
*
At a glance
- Originator Eyenovia
- Class Antihyperglycaemics; Antihypotensives; Decongestants; Ethanolamines; Eye disorder therapies; Mydriatics; Phenethylamines; Pyridines; Small molecules; Urologics
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Mydriasis